Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Q4 Earnings Reports for Aemetis Ameris Bancorp and AMETEK

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Aemetis (NASDAQ: AMTX) released its Q4 earnings report on March 7, 2024. The company reported quarterly losses of $(0.64) per share, which missed the analyst consensus estimate by 88.24%. This represents a 1.59% decrease from the same period last year. Quarterly sales were reported at $70.76 million, falling short of the analyst consensus estimate by 5.21%.

Ameris Bancorp (ABCB) also announced its Q4 earnings on the same date. The company reported earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.12 per share. Revenues for the quarter ended December 2023 were $262.35 million, below the Zacks Consensus Estimate by 1.83%.

AMETEK (AME) provided guidance for its Q4 earnings, expecting adjusted earnings in the range of $1.61-$1.63 per share. This indicates a growth of 6-7% from the previous year’s reported number. The company has a track record of beating earnings estimates and is anticipated to deliver strong performances in segments like Electronic Instruments Group (EIG) and others.

AMTX Stock Shows Positive Momentum on March 7, 2024: Investors Optimistic About Future Prospects

On March 7, 2024, AMTX stock showed some positive momentum as it traded in the middle of its 52-week range and below its 200-day simple moving average. The stock price had increased by $0.05 since the market last closed, representing a 1.53% rise. The stock closed at $3.32 and had risen by an additional $0.04 in pre-market trading.

This increase in stock price could be attributed to a variety of factors, such as positive news about the company, strong financial performance, or overall market conditions. Investors may be feeling optimistic about AMTX’s future prospects, leading to an increase in demand for the stock.

Investors should continue to monitor the stock’s performance and watch for any potential trends that may impact its price movement.

Overall, the performance of AMTX stock on March 7, 2024, showed some positive momentum with a rise in stock price. Investors will be keeping a close eye on the stock to see if this momentum continues in the days ahead.

AMTX Stock Performance: Revenue Growth but Declining Net Income – March 7, 2024 Review

AMTX stock had a mixed performance on March 7, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, AMTX’s total revenue for the past year was $256.51 million, which increased by 21.03% compared to the previous year. The total revenue for the third quarter was $68.69 million, showing a significant increase of 52.27% compared to the previous quarter. However, the company’s net income tells a different story. AMTX reported a net income of -$107.76 million for the past year, which represents a decrease of 128.56% compared to the previous year. On the other hand, the net income for the third quarter was $30.71 million, showing a substantial increase of 221.49% compared to the previous quarter. Earnings per share (EPS) also had a mixed performance for AMTX. The company reported an EPS of -$3.12 for the past year, which decreased by 102.77% compared to the previous year. However, the EPS for the third quarter was $0.79, showing a significant increase of 216.18% compared to the previous quarter. Investors will be closely monitoring the company’s future financial results to see if it can sustain its revenue growth and improve its profitability.

Tags: AMTX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Quantum computing Stock Exchange

Auddia Inc Withdraws S1 Filing to Focus on CapitalEfficient Acquisition Strategy

Computer Services Stock Exchange

Rentokil Initial Reports Record Revenue and Earnings Growth for Fiscal Year 2023

Rentokil Initials Strategic Growth Plans in North America

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com